Medical News

RSS

Aternity FPI Platform selected for Centene's strategic end user experience management initiatives

Aternity Inc., the industry's technology leader in end user experience management solutions for Global 1000 enterprises, announced today that Centene Corporation, a Fortune 500 company and leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals, has selected the Aternity Frontline Performance Intelligence (FPI) Platform for its strategic end user experience management initiatives.

7 Sep 2011

Simulations Plus preliminary fourth quarter revenues increase 6.9% to $1.426 million

Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter of fiscal year 2011, ended August 31, 2011 (4QFY11), and for the entire fiscal year 2011 (FY11).

7 Sep 2011

PSI to develop statewide enterprise content management solution for Maryland DHR

Policy Studies Inc. (PSI), a recognized expert in systems design and development for health and human services (HHS) programs, announced today that the Maryland Department of Human Resources (DHR) awarded PSI a 34-month contract to develop and implement a statewide enterprise content management solution (ECMS) to help manage and store DHR's hundreds of thousands of documents. Initial work on the project started on August 1.

7 Sep 2011

FDA to review bone drugs; CDC reports parasite may be a risk to blood supply

Two advisory panels of the Food and Drug Administration will consider on Friday whether to recommend requiring women who use popular bone drugs like Fosamax to take "drug holidays" because of rising concerns about rare side effects with long-term use, according to people involved in the review.

7 Sep 2011

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.

7 Sep 2011

Hi-Tech Pharmacal first quarter sales increase 43% to $56.2 million

Hi-Tech Pharmacal Co., Inc. today reported results for the Company's fiscal first quarter ended July 31, 2011.

7 Sep 2011

St. Jude Medical receives approval for CRT-D quadripolar pacing system in India

St. Jude Medical, Inc., a global medical device company, today announced the approval of the industry's first quadripolar pacing system for cardiac resynchronization therapy defibrillators (CRT-Ds) in India. The Promote Quadra CRT-D offers physicians the ability to more effectively and efficiently manage the ever-changing pacing needs of patients with heart failure.

7 Sep 2011

Loss of estrogen receptor alpha protein may lead to metabolic syndrome

UCLA researchers demonstrated that loss of a key protein that regulates estrogen and immune activity in the body could lead to aspects of metabolic syndrome, a combination of conditions that can cause Type 2 diabetes, atherosclerosis and cancer. Called estrogen receptor alpha, this protein is critical in regulating immune system activity such as helping cells suppress inflammation and gobble-up debris.

7 Sep 2011

First Edition: September 7, 2011

"Publicly, consumer and patient advocates continue to cheer wildly for last year's health care law. Behind the scenes, however, some worry that they are losing a few key battles to the insurance and business communities.

7 Sep 2011

First aesthetic laser device for long-term reduction in appearance of cellulite

Cynosure, Inc., a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, received a medical device licence issued by Health Canada for the Company's Cellulaze Cellulite Laser Workstation for the reduction in the appearance of cellulite.

7 Sep 2011

Researchers rethink fenretinide for prevention of oral cancer

Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.

7 Sep 2011

Dwindling donor funding in Burundi leads to national shortage of ARVs

"Burundian NGOs say at least 20 people have died" as a result of a "months-long shortage" of antiretroviral drugs (ARVs), although "Ministry of Health officials could not be reached to confirm the number of people affected," PlusNews reports.

7 Sep 2011

Human brain places more value on winning in a social setting

A new USC study explains why people take stupid chances when all of their friends are watching that they would never take by themselves. According to the study, the human brain places more value on winning in a social setting than it does on winning when you're alone.

7 Sep 2011

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused by bioterrorism threats such as plague and tularemia, as well as more certain life-threatening infections, known as Gram-negative infections, associated with prolonged hospitalization.

7 Sep 2011

President's tough tasks before election: Deficit plan, sell health reform

President Obama will be crafting his own deficit-reduction plan and will also shape an election strategy for the health law.

7 Sep 2011

Physical, sexual abuse and threats prevent adolescent girls from having their partner use condoms

Partner abuse leads to HIV infection, and black women are most at risk. A new study at the University of Pennsylvania School of Nursing has found that 46 percent of African-American adolescent girls report that their partner did not use a condom the last time they had sex -- often because of partner abuse. The girls described physical and sexual abuse and threats as preventing them from having their partner use condoms.

7 Sep 2011

Business leaders concerned about economic impact of health law

To many Republicans and business leaders, there's little doubt: The health care law and sweeping new Wall Street regulation - two of President Obama's signature legislative victories - are causing uncertainty and killing jobs. Take, for example, a massive public relations campaign organized by House Republican leaders.

7 Sep 2011

The ABCs of proper brushing

For kids, brushing their teeth isn't always top of mind, and getting them to brush properly can be a real challenge for parents. But getting back into daily school routines is a great time to make sure kids are brushing often - and properly.

7 Sep 2011

Top-line results from Auxilium XIAFLEX palpable cord study in Dupuytren's contracture subjects

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from a pilot clinical study to assess safety, tolerability, and multiple-dose pharmacokinetics of XIAFLEX (collagenase clostridium histolyticum) in adult Dupuytren's contracture subjects with multiple palpable cords.

7 Sep 2011

Scientists discover 29 new genetic variants linked with MS

Multiple sclerosis is primarily an immunological disease. Scientists at Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine (MDC) have in succeeded, in collaboration with 23 research teams from 15 different countries, in discovering a total of 29 new genetic variants that are involved in the genesis of multiple sclerosis (MS), an inflammatory disease of the nervous system.

7 Sep 2011